Posts by rw-admin
Breath Biopsy Platform Wins UK’s Most Prestigious Award for Innovative Engineering
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced the team behind the Company’s unique Breath Biopsy® platform has been named the winner of the MacRobert Award 2018 by the Royal Academy of Engineering. Owlstone Medical’s Breath Biopsy platform, including the ReCIVA Breath Sampler, has opened up the potential for earlier diagnosis…
Read MoreBoston Scientific to Pay $202 Million for Cryterion Medical
Boston Scientific Corporation today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). The addition of this cryoballoon platform positions the company as the first to have both cryothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies in its portfolio. Boston…
Read MoreFlorida Hospital First in State to Adopt BodyTom Elite, Samsung’s Updated CT Scanner
DANVERS, MA, June 7, 2018 – NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., a leader in medical imaging technology, announced today that Florida Hospital in Orlando, Fl., added the BodyTom® Elite, the newly upgraded, portable, 32-slice computed tomography scanner, to their brachytherapy suite. The BodyTom Elite improves the patient experience, patient safety and workflow efficiency by…
Read MoreBrain Stimulation May Reduce Desire to Commit Sexual Assault
Stimulating the prefrontal cortex, the part of the brain responsible for controlling complex ideas and behaviors, can reduce a person’s intention to commit a violent act by more than 50 percent, according to research published in the Journal of Neuroscience from the University of Pennsylvania and Nanyang Technological University. What’s more, using such a minimally invasive technique, called transcranial direct-current…
Read MoreMassachusetts Biotech Sees Record Year for IPOs
It’s been a pretty good year for mergers and acquisitions in the biopharma industry, with Takeda Pharmaceutical buying Shire for $62.2 billion, and the year starting with Sanofi buying Bioverativfor $11.6 billion and then Ablynx for $4.8 billion. Celgene acquired Juno Therapeutics for $9 billion, shortly after buying Impact Biomedicines for $1.1 billion. But the landscape for initial public offerings (IPOs) has been excellent as well, particularly in Massachusetts, which has recorded 13 IPOs…
Read MoreMiMedx CEO and President Out Amid Corporate Turmoil
MiMedx, the Marietta biopharma company rocked by allegations of inflated earnings and improper sales practices, said Monday the company’s longtime chairman and CEO has resigned. Parker H. “Pete” Petit, a fixture in metro Atlanta’s business community, resigned both as CEO and chairman, though he will remain a member of the MiMedx board, the company said in…
Read MoreBIOLIFE4D Successfully 3D Bioprints Human Heart Tissue
BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch. The scientific milestone was accomplished within days of the May opening of the Company’s new research facility at JLABS in…
Read More“Smart Stent” Monitors Blood Flow, Detects Narrowing of Arteries
Vascular stents are some of the most commonly implanted medical devices, keeping millions of arteries open to uninterrupted blood flow. Though they tend to work well at first, too many end up being re-stenosed by new deposits of plaque and scar tissue often forms in the vicinity, blocking blood flow through the stent. Typically, renewed…
Read MoreGE to Spin Off Healthcare Division
After a year of soul searching and strategic review, GE announced its move today to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt. Healthcare is one of eight businesses GE operates that also…
Read MoreFDA Approves First Marijuana-derived Drug for Severe Forms of Epilepsy
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana.…
Read More